6901 logo

Diamond Biofund Inc. Stock Price

TWSE:6901 Community·NT$12.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6901 Share Price Performance

NT$14.25
-10.30 (-41.96%)
NT$14.25
-10.30 (-41.96%)
Price NT$14.25

6901 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks
0 Rewards

Diamond Biofund Inc. Key Details

-NT$1.1b

Revenue

NT$0

Cost of Revenue

-NT$1.1b

Gross Profit

NT$101.5m

Other Expenses

-NT$1.2b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-1.38
100.00%
109.46%
0%
View Full Analysis

About 6901

Founded
2013
Employees
33
CEO
You-Mei Wu
WebsiteView website
www.diamondbiofund.com/tc/index.htm

Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.

Recent 6901 News & Updates

Recent updates

No updates